© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Editorial |
On the Road to an Impact Factor for eCAM
Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095-1763, USA
| The first 10% of the full text of this article appears below. |
Last year 2006 was indeed a fruitful year from many points of view and, mostly with respect to eCAM, attempts were made to broaden the scope of influence and to focus on what I deemed regions of eCAM strength. To that end, I spent nearly three months at the Institute for Advanced Studies, University of Bologna with Prof. Claudio Franceschi as my host—a convenient launching point that allowed interaction with eight other members of the Editorial Board in northern Italy (1). Another area that received some attention was the National Research Center, Dokki, Cairo, Egypt, where there is a wealth of activity especially using products from plants and animals. The Antiaging Meeting in Vienna was particularly enlightening and as with all meetings, my focus was on speaking the
For reprints and all correspondence: Edwin L. Cooper, Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095-1763, USA. Tel: +1-310-825-9567; Fax: +1-310-825-2224; E-mail: ecam@mednet.ucla.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. L. Cooper eCAM: Moving Forward Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 399 - 400. [Full Text] [PDF]
|
|